These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35064153)

  • 1. Metabolic adjustments of blood-stage Plasmodium falciparum in response to sublethal pyrazoleamide exposure.
    Tewari SG; Kwan B; Elahi R; Rajaram K; Reifman J; Prigge ST; Vaidya AB; Wallqvist A
    Sci Rep; 2022 Jan; 12(1):1167. PubMed ID: 35064153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors.
    Tewari SG; Elahi R; Kwan B; Rajaram K; Bhatnagar S; Reifman J; Prigge ST; Vaidya AB; Wallqvist A
    Malar J; 2023 Feb; 22(1):56. PubMed ID: 36788578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum.
    Vaidya AB; Morrisey JM; Zhang Z; Das S; Daly TM; Otto TD; Spillman NJ; Wyvratt M; Siegl P; Marfurt J; Wirjanata G; Sebayang BF; Price RN; Chatterjee A; Nagle A; Stasiak M; Charman SA; Angulo-Barturen I; Ferrer S; Belén Jiménez-Díaz M; Martínez MS; Gamo FJ; Avery VM; Ruecker A; Delves M; Kirk K; Berriman M; Kortagere S; Burrows J; Fan E; Bergman LW
    Nat Commun; 2014 Nov; 5():5521. PubMed ID: 25422853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.
    Maron MI; Magle CT; Czesny B; Turturice BA; Huang R; Zheng W; Vaidya AB; Williamson KC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1492-9. PubMed ID: 26711768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Survival Adaptations of Plasmodium falciparum Exposed to Sublethal Doses of Fosmidomycin.
    Tewari SG; Rajaram K; Swift RP; Reifman J; Prigge ST; Wallqvist A
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization and chemical inhibition of PfATP4-associated Na
    Rosling JEO; Ridgway MC; Summers RL; Kirk K; Lehane AM
    J Biol Chem; 2018 Aug; 293(34):13327-13337. PubMed ID: 29986883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum.
    Dumont L; Richardson MB; van der Peet P; Marapana DS; Triglia T; Dixon MWA; Cowman AF; Williams SJ; Tilley L; McConville MJ; Cobbold SA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs.
    Spillman NJ; Kirk K
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):149-62. PubMed ID: 26401486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.
    Dousti M; Manzano-Román R; Rashidi S; Barzegar G; Ahmadpour NB; Mohammadi A; Hatam G
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33202000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
    Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+ Influx Induced by New Antimalarials Causes Rapid Alterations in the Cholesterol Content and Morphology of Plasmodium falciparum.
    Das S; Bhatanagar S; Morrisey JM; Daly TM; Burns JM; Coppens I; Vaidya AB
    PLoS Pathog; 2016 May; 12(5):e1005647. PubMed ID: 27227970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.
    Fisher GM; Cobbold SA; Jezewski A; Carpenter EF; Arnold M; Cowell AN; Tjhin ET; Saliba KJ; Skinner-Adams TS; Lee MCS; Odom John A; Winzeler EA; McConville MJ; Poulsen SA; Andrews KT
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293381
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites.
    Guggisberg AM; Frasse PM; Jezewski AJ; Kafai NM; Gandhi AY; Erlinger SJ; Odom John AR
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.
    Cobbold SA; McConville MJ
    Methods Mol Biol; 2019; 1859():225-239. PubMed ID: 30421232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term metabolic adjustments in Plasmodium falciparum counter hypoxanthine deprivation at the expense of long-term viability.
    Tewari SG; Rajaram K; Schyman P; Swift R; Reifman J; Prigge ST; Wallqvist A
    Malar J; 2019 Mar; 18(1):86. PubMed ID: 30890151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.